TD SYNNEX Other Income (Expense) increased by 26562.2% to $19.58M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1254.6%, from -$1.70M to $19.58M.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$755.00K | $4.80M | -$4.27M | -$6.26M | -$1.85M | -$156.00K | -$4.16M | -$2.37M | -$2.88M | -$3.09M | -$1.52M | -$1.23M | -$1.70M | -$79.00K | $792.00K | -$74.00K | $19.58M |
| QoQ Change | — | +735.2% | -189.0% | -46.6% | +70.4% | +91.6% | <-999% | +43.1% | -21.6% | -7.2% | +50.9% | +19.3% | -38.4% | +95.3% | >999% | -109.3% | >999% |
| YoY Change | — | — | — | -728.5% | -138.6% | +96.3% | +33.4% | -28.0% | <-999% | +25.8% | +36.0% | — | +41.2% | +97.4% | +152.2% | +94.0% | >999% |